Found "AI": 1,133 results
Sort by
Relevance

Developing an Evidence Guide to Strengthen Public Investment Decisions for Digital Health Technologies in Low- and Middle-Income Countries

Digital health technologies (e.g., wearables, electronic health records, and artificial intelligence tools) are increasingly recognized for their potential to enhance care quality, efficiency, and reach of healthcare services while potentially reducing costs [1]. Landscape reviews have shown increasing investments by governments and other stakehold

Coordinated Procurement: Lessons Learned Globally and Potential Application In Asean and Implications for Antibiotics

Access to effective and affordable antibiotics remains a major challenge globally, particularly in low- and middle-income countries. To address this, SECURE, a global initiative led by World Health Organisation (WHO) and the Global Antibiotic Research and Development Partnership (GARDP) aims to work with countries to pioneer new approaches to ensur

Shiela Marie Selisana, PhD

Shiela is an Associate at the HITAP International Unit. She holds a doctoral degree in Microbiology and currently leads antimicrobial resistance (AMR)-related projects at HITAP, in collaboration with international partners such as the University of Oxford, City St George’s University of London, and global organizations including the World Health Or

Examining coordinated procurement mechanisms and related regulatory policies for healthcare products in ASEAN: case studies and lesson learned

Achieving universal access to essential healthcare products remains a critical challenge across low- and middle-income countries (LMICs). While individual countries may have made notable strides in strengthening their procurement and regulatory systems, regional disparities in access, affordability,

Global Antibiotic Policy Initiative (GAPi)

Antimicrobial resistance (AMR) is one of the most pressing public health challenges worldwide. AMR occurs when antimicrobials, such as antibiotics, become ineffective against the microorganisms that cause disease. This ineffectiveness can lead to serious infections, increased mortality, and significant economic losses.The Global Antibiotic Policy I

Post-COVID Health System Strengthening

This project aims to strengthened Thai health system post COVID times and has been started since 1 April 2022 until the end of March 2023. There are five sub-projects under the grant consisting of environmental health, local governance, health financing, and digital technology.post COVID

Summary: Prince Mahidol Award Conference (PMAC) 2026 Side Meeting on “Antimicrobial Resistance (AMR) in An Ageing World: Policy Challenges and Equity Implications”

Acknowledgements This report was prepared by Dr. Shiela Marie Selisana and Ms. Thitipanchaya Panya from the Health Intervention and Technology Assessment Program Foundation (HITAP) and reviewed by Ms. Saudamini Vishwanath Dabak. The authors are grateful to Dr. Zin Nwe Win for her invaluable as

Meeting Summary: Global Antibiotic Policy Initiative (GAPi) Internal Meeting

Acknowledgements This report was prepared by Dr. Zin Nwe Win, Dr. Shiela Marie Selisana, and Ms. Thitipanchaya Panya from the Health Intervention and Technology Assessment Program Foundation (HITAP) and reviewed by Ms. Saudamini Vishwanath Dabak. The meeting was conducted in collaboration with

PMAC 2026: HITAP highlighted innovations and launched global projects and journals, reflecting the power of evidence at both community and international levels.

In the Prince Mahidol Award Conference 2026 (PMAC 2026), held from January 26–31, 2026, at the Centara Grand & Bangkok Convention Centre at CentralWorld, the Health Intervention and Technology Assessment Program Foundation (HITAP) participated in supporting and driving the international exchange
10 / Page